Search alternatives:
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
latest decrease » greatest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
way decrease » a decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
three way » three days (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
latest decrease » greatest decrease (Expand Search), largest decreases (Expand Search), latency decreased (Expand Search)
way decrease » a decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
three way » three days (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
3x3 Latin square design.
Published 2025“…The results show that although young drivers perform better with the Augmented Reality (AR) display in various complex scenarios, particularly in high-complexity scenarios (the fixation duration with AR display was significantly shorter than that with Pseudo-3D (P3D) display; P = 0.012). However, the advantages of the AR display will weaken as the complexity of the scenarios decreases. …”
-
9
B2 decreases glycolytic intermediates in cells.
Published 2025“…Other abbreviations: HGA, DL-hydroxyglutaric acid; PEP, phosphoenolpyruvic acid; 3-PGA, 3-phosphoglyceric acid; G3P; glyceraldehyde 3-phosphate; Data (n = 5) are shown as mean±SD. …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
Loxoprofen and SB225002 administration decreased sound stress exposure-induced hyperalgesia.
Published 2025“…Mice treated with loxoprofen (500 mg/kg) or SB225002 (3 mg/kg) showed significantly decreased response times to the filament compared to Stress + saline group (Stress + loxoprofen (500 mg/kg), 30 min after administration, **<i>P</i> < 0.01, 60 min after administration, ***<i>P</i><i> <i><</i> </i>0.001; Stress + SB225002 (3 mg/kg), 60 min after administration, *<i>P</i> < 0.05). 2-way ANOVA <i>post-hoc</i> Bonferroni test. …”
-
18
-
19
Cost-effectiveness results of a three-way sensitivity analysis assessing bNAb efficacy, cost, and maternal HIV prevalence/incidence, by country.
Published 2025“…<p>We conducted a three-way sensitivity analysis on the impact of bNAb cost per dose (vertical axis), efficacy per dose (horizontal axis), and maternal HIV prevalence (left to right panels) on the cost-effective bNAb strategy in the three countries examined: Côte d’Ivoire (Panels A-C), South Africa (Panels D-F), and Zimbabwe (Panels G-I). …”
-
20
BrdU incorporation is elevated in clrn1-/- zebrafish at 4 mpf and decreases with age.
Published 2025“…(*p<0.05; **p<0.01; One-way ANOVA). Scale bar=10 µm. Data points are averages of 3 sections per retina. n=10 retina per genotype for each time-point.…”